Antimicrobials Flashcards
(39 cards)
Acyclovir
MOA: Inhibits viral replication by suppressing DNA synthesis Indications: - Topical: HSV - PO: HSV/VSV - IV: HSH/VSV in immunocompromised patients Adverse Effects: - IV phlebitis - Nephrotoxicity (increased BUN/creatinine) - Neurotoxicity Nursing Considerations: - Monitor IV site - Monitor renal & neuro status
Ganciclovir
MOA: Inhibits viral replication by suppressing DNA synthesis
Indications:
- CMV in immunocompromised patients
Adverse Effects:
- Bone Marrow Suppression: thrombocytopenia/granulocytopenia
- Teratogenicity
Nursing Considerations:
- Monitor CBC for changes in WBC & PLT
- Co-adminsiter with granulocyte colony-stimulating factor (GCSF)
- PO with food
- Use of contraception
Interferon Alfa
MOA: Interferes with... - Viral entry - Viral RNA & protein synthesis - Viral assembly/release Indications: - Hepatitis B Virus - Hepatitis C Virus Adverse Effects: - Flu-like s/s - Severe depression - Bone marrow suppression Nursing Considerations: - Monitor liver s/s & enzymes - Monitor mental status - Monitor CBC - Admin. acetaminophen for flu-like s/s
Ribavirin
MOA: Increases interferon alfa effects Indications: - Hepatitis C treatment along with interferon alfa Adverse Effects: - Flu-like s/s - Severe depression - Bone marrow suppression - Hemolytic anemia - Fetal injury! Nursing Considerations: - Monitor liver s/s & enzymes - Extended contraception use (60 days after tx) - Monitor mental status - Monitor CBC - Admin. acetaminophen for flu-like s/s - Caution with sulfa allergies!
Simeprevir
Protease Inhibitor MOA: Inhibits viral protease & replication Indications: - HCV Adverse Effects: - Headache, nausea, fatigue - Hepatic injury - Photosensitivity - Rash Nursing Considerations: - Monitor hepatitis s/s & liver enzymes - Caution with sulfa allergies!
Daclatasvir
NS5A Inhibitor MOA: Inhibits NS5A protein which is necessary for viral replication and assembly Indications: - HCV Adverse Effects: - Headache & fatigue - Possible anemia Nursing Considerations: - Monitor hepatitis s/s & liver enzymes - Numerous drug interactions!
Oseltamivir
MOA: Inhibits neuraminidase to prevent viral replication and prevents newly formed viral particles from spreading to other cells
Indications:
- Influenza virus
Adverse Effects:
- Generally well-tolerated
- N/V
- Hypersensitivity & neuropsychiatric (rare)
Nursing Considerations:
- Rapid flu testing
- Tx should be started 48-72 after onset of symptoms
- Monitor for allergic reactions
Abacavir
Nucleoside Reverse Transcriptase Inhibitor (NRTI) MOA: Acts as a substrate for reverse transcriptase to inhibit replication & DNA synthesis Indications: - HIV Adverse Effects: - Lactic Acidosis - Hepatic Steatosis - Hypersensitivity - Increase risk of MI Nursing Considerations: - Genetic Testing for hypersensitivity risk - Monitor LA, HA, & MI s/s
Efavirenz
Non-Nucleoside Reverse Transcriptase Inhibitor
MOA: Binds to active center of reverse transcriptase to prevent replication & DNA synthesis
Indications:
- HIV
Adverse Effects:
- CNS s/s
- Rash
- Teratogenicity
Nursing Considerations:
- Numerous drug interactions
- Take on empty stomach to reduce CNS effects
Lopinavir/Ritonavir
Protease Inhibitor MOA: Inhibits protease, an enzyme needed for HIV maturation; ritonavir boosts lopinavir effects Indications: - HIV Adverse Effects: - Diarrhea - Hyperglycemia & new-onset diabetes - Lipodystrophy & hyperlipidemia - Prolonged PR & QT interval Nursing Considerations: - Cardiac monitoring (telemetry) - Monitor glucose levels
Raltegravir
Integrase Strand Transfer Inhibitor (INSTI) MOA: inhibit integrase, an enzyme needed for HIV DNA insertion into host cell; prevents replication Indications: - HIV Adverse Effects: - Generally well-tolerated - Elevated liver enzymes - Hypersensitivity reactions - Resistance more common Nursing Considerations: - Assess for hepatic injury & trend LFT - Report skin manifestations & stop med immediately!
Enfuvirtide
Fusion inhibitor MOA: Inhibits HIV fusion into host cell; medication binds to lipid bilayer Indications: - HIV Adverse Effects: - SQ injection site reactions - Bacterial pneumonia - Hypersensitivity Nursing Considerations: - Administer SQ - Monitor respiratory & integumentary s/s
Maraviroc
CCR5 Antagonist
MOA: Inhibits CCR5, a co-receptor needed for HIV entry into host cell
Indications:
- HIV
Adverse Effects:
- Hepatic Injury
- Increased risk for CV-events (MI, CVA, etc.)
Nursing Considerations:
- Assess for liver injury
- Assess CV status
- CCR5 tropism assay may be performed to ensure that HIV strain is compatible with this medication
Hydroxychloroquine
Antimalarial & DMARD MOA: may interfere with binding of SARS-CoV-2 spike protein to the host cell by reducing glycosylation of ACE2 Indications: - SARS-CoV-2 FDA EUA (revoked June 2020) Adverse Effects: - Heart failure & cardiac dysrhythmias - Neuropsychiatric effects (hallucinations, psychosis, agitation, etc.) - Hemolytic anemia - Severe hypoglycemia - Skeletal muscle myopathy - Retinal Damage Nursing Considerations: - Baseline exam prior to starting tx - Baseline EKG - Monitor cardiac s/s - Monitor blood glucose
Remdesivir
IV SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor
MOA: Inhibits RNA polymerase; results in delayed chain termination during replication
Indications:
- COVID-19 infection requiring hospitalization
Adverse Effects:
- Elevated AST & ALT
- Hypersensitivity reactions (may be severe - anaphylaxis, etc.)
- Prolonged prothrombin time (PT)
Nursing Considerations:
- Monitor CMP & liver s/s
- Monitor renal function for impairment
- Discontinue infusion if hypersensitivity
Penicillin G
MOA: weakens the cell wall by targeting PBP’s & causing the bacterial cell to take up excess water and lyse
Indications:
- Gram-positive bacterial
- Strep, staph, enterococci, etc.
Adverse Effects:
- Allergy (cross-allergy with cephalosporins)
Nursing Considerations:
- Assess for hx of allergic rx
- Monitor infection status (CBC, VS, & s/s)
- Increased risk of C-diff infection (co-administer lactobacillus)
Cephalosporin
MOA: weakens the cell wall by targeting PBP’s & causing the bacterial cell to take up excess water and lyse
Indications:
- As generations progress, more Gram-neg., anaerobic, and beta-lactamase resistance, and BBB selectivity.
Adverse Effects:
- Allergy (cross-allergy with penicillins)
- Disulfiram-like reaction with alcohol
Nursing Considerations:
- Assess for hx of allergic rx
- Monitor infection status (CBC, VS, & s/s)
- Increased risk of C-diff infection (co-administer lactobacillus)
Piperacillin/Tazobactam
MOA: Penicillin-like MOA plus beta-lactamase inhibition through tazobactam
Indications:
- Gram-positive & negative
- Anaerobic coverage
Adverse Effects:
- Allergy!
Nursing Considerations:
- Assess for hx of allergic rx
- Monitor infection status (CBC, VS, & s/s)
- Increased risk of C-diff infection (co-administer lactobacillus)
- Monitor IV site (IV ONLY MED!)
Imipenem/Cilastatin
MOA: Binds specifically to PBP 1 & 2 to weaken cell wall & can resist beta-lactamases; cilastatin prevents rapid renal excretion Indications: - Very broad spectrum - MRDO for bone, joint, SSTI, UTI, intraabdominal, and pelvic infx Adverse Effects: - Generally well-tolerated - GI effects most common - Superinfection - Seizures Nursing Considerations: - Reserve for use in patients with infections NOT covered by other antibiotics - Seizure precautions if needed
Vancomycin
MOA: Weakens cell wall by binding to precursors of cell wall synthesis
Indications:
- Gram-positive for bone, joint, and blood infx
- MRSA & C-diff
Adverse Effects:
- Nephrotoxicity
- Ototoxicity
- Red-man syndrome (flushing, rash, pruritus, etc.)
Nursing Considerations:
- Monitor troughs (draw 30 mins before admin.)
- Monitor CMP for renal function
- Avoid use with other nephrotoxic drugs
Doxycycline
MOA: bacteriostatic; binds to 30S ribosomal subunit to prevent binding of tRNA to mRNA which prevents addition of amino acids to growing peptide chain
Indications:
- Broad-spectrum coverage
- Rickettsial diseases, chlamydial diseases, Lyme disease, cholera, Mycobacterium pneumonia, anthrax, brucellosis, H. pylori, etc.
Adverse Effects:
- GI most common
- Bone growth suppression and teeth discoloration in children
- Alterations in normal flora (superinfection)
- Photosensitivity
Nursing Considerations:
- Decreased absorption with metal ions found in dairy products, laxatives, antacids, etc.
- Interacts with anticoagulants and oral contraceptives
Azithromycin
Macrolide
MOA: bacteriostatic; binds to 50S ribosomal subunit to block addition of new amino acids to growing peptide chain
Indications:
- Most Gram-pos.; some Gram-neg.
- PCN alternative if allergic
- First line tx for pertussis, diphtheria, chlamydia, respiratory, GI, GU infx, & SSTI
Adverse Effects:
- GI most common
- QT prolongation
- Hepatotoxicity
- Ototoxicity
Nursing Considerations:
- Admin. PO on empty stomach except if GI upset
- Avoid in patients with pre-existing QT-prolongation; monitor on telemetry
- Can increase half-lives of several medications, especially theophylline & warfarin
Clindamycin
Lincosamide
MOA: similar to macrocodes; bacteriostatic; binds to 50S ribosomal subunit to block addition of new amino acids to growing peptide chain
Indications:
- Gram-pos. & Gram-neg anaerobes
- Most Gram + aerobes
- Bone, GU, intraabdominal, pneumonia, septicemia, and SSTI.
- First line tx for severe strep group A and gangrene
Adverse Effects:
- Severe/fatal C-diff CDAD
- Non-C. diff Diarrhea
Nursing Considerations:
- Monitor for C-diff. s/s
- Excessive neuromuscular blockade & respiratory paralysis with concurrent use of NMBA
- Watch I/O & hypotension with IV infusions
Linezolid
Oxazolidinone MOA: Bacteriostatic; binds to 23S portion of 50S ribosomal subunit to block formation of initiation complex Indications: - Very broad spectrum coverage, including MRDO - VRE/MRSA - CAP/HCAP - Comp. & Uncomp. skin infections Adverse Effects: - Headache - N/V/D - Myelosuppression - Neuropathy Nursing Considerations: - Monitor CBC & I/O - Admin with food to limit GI upset - Monitor for drug interactions with MAOi (HTN crisis) & SSRI (serotonin syndrome)